Carbohydrate Metabolism & Glucose Homeostasis CM

Glycolysis converts one six-carbon glucose molecule into two three-carbon pyruvate molecules in the cytosol. The pathway has an investment phase and a payoff phase. Glucose is first phosphorylated to glucose-6-phosphate by hexokinase in many tissues or glucokinase in hepatocytes and pancreatic beta cells. Phosphorylation traps glucose-derived carbon within the cell because glucose-6-phosphate does not freely leave through ordinary glucose transporters.

Glucose-6-phosphate is rearranged to fructose-6-phosphate. Phosphofructokinase-1 then forms fructose-1,6-bisphosphate, a major regulated and essentially irreversible step. The six-carbon intermediate is split into three-carbon phosphates; triose-phosphate isomerase allows both carbon fragments to proceed through the same downstream sequence.

Glyceraldehyde-3-phosphate dehydrogenase oxidizes its substrate and generates NADH while adding inorganic phosphate. Subsequent substrate-level phosphorylation generates ATP. Phosphoglycerate mutase and enolase rearrange the intermediate, and pyruvate kinase catalyses the final ATP-generating step to pyruvate. Net glycolysis yields two ATP and two NADH per glucose under the usual accounting.

Hexokinase/glucokinase, PFK-1 and pyruvate kinase represent key irreversible control points. PFK-1 integrates energy status and hormonal regulation through metabolites including ATP, AMP and fructose-2,6-bisphosphate. This is why glycolysis should be understood as regulated carbon flow, not a memorized chain of names.

Hexokinase is widely distributed, has relatively high affinity for glucose and is inhibited by its product glucose-6-phosphate. These properties help many tissues phosphorylate glucose even when circulating glucose is not high.

Glucokinase is prominent in liver and pancreatic beta cells. It has a higher Km and greater capacity, allowing hepatic glucose phosphorylation to rise substantially when portal glucose increases after a meal. In liver it is regulated differently from ordinary hexokinase and participates in postprandial glucose handling.

The clinical importance is conceptual: different tissues use enzyme isoforms suited to their physiological role. The liver can buffer postprandial glucose while other tissues maintain access at lower concentrations.

Pyruvate sits at a metabolic branch point. In aerobic mitochondria-containing cells it can be converted to acetyl-CoA by the pyruvate dehydrogenase complex. It can also be carboxylated to oxaloacetate, especially when gluconeogenic or anaplerotic needs are present. Through transamination it can form alanine.

Reduction of pyruvate to lactate by lactate dehydrogenase regenerates NAD+ from NADH. This regeneration is essential when cytosolic NAD+ would otherwise become limiting for glycolysis. Mature red cells produce lactate continuously because they lack mitochondria; exercising muscle may increase lactate production when glycolytic flux exceeds oxidative handling.

Lactate is not simply metabolic waste. It can circulate to tissues that oxidize it or to liver where its carbon can contribute to gluconeogenesis. Lactic acidosis develops when production and utilization become sufficiently imbalanced in a clinical context.

The pyruvate dehydrogenase complex resides in mitochondria and converts pyruvate to acetyl-CoA through oxidative decarboxylation. The reaction produces NADH and carbon dioxide and is effectively irreversible in human metabolism, making it a decisive connection between glycolysis and oxidative acetyl-CoA metabolism.

The complex uses multiple enzyme components and cofactors derived from vitamins, classically including thiamine pyrophosphate, lipoate, CoA, FAD and NAD+. Its activity is controlled by product availability, energy state and reversible phosphorylation. High-energy signals tend to suppress unnecessary pyruvate oxidation, whereas conditions requiring fuel oxidation favour activity.

Because acetyl-CoA cannot be converted back to pyruvate in a way that produces net glucose in humans, the irreversibility of PDH helps explain why even-chain fatty acids do not provide net carbon for glucose synthesis.

Acetyl-CoA condenses with oxaloacetate to form citrate. Through a sequence involving isomerization, oxidative decarboxylations, substrate-level phosphorylation and regeneration of oxaloacetate, the TCA cycle captures energy mainly as NADH and FADH2. These reduced cofactors feed the respiratory chain.

The cycle is amphibolic: it participates in fuel oxidation while also supplying intermediates for biosynthesis. Citrate can contribute to lipid synthesis, alpha-ketoglutarate and oxaloacetate participate in amino-acid metabolism, and succinyl-CoA connects with heme synthesis. Withdrawal of intermediates requires anaplerotic reactions to replenish the cycle.

Regulated steps respond to energy state and substrate/product signals. The purpose is to match acetyl-CoA oxidation with cellular energy demand rather than simply spin the cycle at a fixed speed.

Glycogen is a branched glucose polymer stored mainly in liver and skeletal muscle. Glycogenesis converts glucose-6-phosphate through glucose-1-phosphate and an activated UDP-glucose donor into glycogen. Glycogen synthase extends alpha-1,4-linked chains, while branching enzyme creates alpha-1,6 branches that increase solubility and provide many terminal sites for rapid synthesis or degradation.

Glycogenolysis uses glycogen phosphorylase to release glucose-1-phosphate from alpha-1,4 linkages; debranching activity handles branch points. Phosphoglucomutase converts glucose-1-phosphate to glucose-6-phosphate.

Liver and muscle glycogen have different physiological purposes. Liver contains glucose-6-phosphatase and can release free glucose to support blood glucose. Skeletal muscle lacks this final capability and uses its glycogen locally for ATP generation. Hormonal regulation therefore has organ-specific consequences.

Gluconeogenesis synthesizes glucose mainly in liver and, especially with prolonged fasting, kidney from precursors such as lactate, glycerol and glucogenic amino-acid carbon. It is not glycolysis run backward because the three strongly irreversible glycolytic steps require bypass enzymes.

Pyruvate is converted to oxaloacetate by pyruvate carboxylase and then to phosphoenolpyruvate through phosphoenolpyruvate carboxykinase. Fructose-1,6-bisphosphatase bypasses PFK-1. Glucose-6-phosphatase completes release of free glucose in tissues that express it.

Gluconeogenesis consumes energy. Reciprocal regulation with glycolysis reduces futile cycling: hormonal and allosteric signals tend to favour one direction according to nutritional state. During fasting this pathway protects glucose supply for tissues with obligatory or substantial glucose requirements.

In the Cori cycle, lactate produced by anaerobic glycolysis in tissues such as exercising muscle or continuously by red blood cells travels to liver. Hepatic gluconeogenesis converts lactate carbon back to glucose, which can return to peripheral tissues. Energy expenditure is shifted toward liver while glycolytic tissues regenerate NAD+.

The glucose–alanine cycle transfers both carbon and nitrogen. Muscle transfers amino nitrogen to pyruvate, producing alanine. Alanine travels to liver, where its nitrogen can enter urea formation and its carbon skeleton can support gluconeogenesis.

These cycles demonstrate inter-organ metabolism: a pathway cannot always be understood by looking at one cell in isolation.

The pentose-phosphate pathway begins from glucose-6-phosphate and contains an oxidative phase that generates NADPH and ribulose-5-phosphate, followed by nonoxidative carbon rearrangements that connect pentose metabolism with glycolytic intermediates.

NADPH supports reductive biosynthesis and maintains antioxidant systems, including reduction of glutathione. Red blood cells are especially dependent on the pathway because they lack mitochondria and face continuous oxidant exposure while carrying oxygen.

Ribose-5-phosphate supports nucleotide synthesis. The reversible nonoxidative reactions allow cells to adjust production of NADPH, ribose and glycolytic intermediates according to need. Defects affecting NADPH generation can therefore become clinically apparent during oxidant stress.

After a carbohydrate-containing meal, increased insulin signalling promotes glucose uptake in insulin-responsive tissues, hepatic and muscle glycogen synthesis, glycolytic utilization and lipid storage while suppressing excessive hepatic glucose production. The liver acts as a metabolic buffer, storing or processing incoming carbon.

During fasting, lower insulin and relatively greater glucagon signalling favour hepatic glycogenolysis initially and increasingly gluconeogenesis as fasting continues. Adipose lipolysis supplies fatty acids for many tissues and glycerol for gluconeogenesis, reducing pressure to oxidize glucose everywhere.

In diabetes mellitus, inadequate effective insulin action disturbs this coordination. Hyperglycaemia is only one component; hepatic glucose production, adipose lipolysis, ketone metabolism, protein turnover, osmotic water loss and electrolyte shifts can all become involved. Mechanistic integration explains the clinical picture better than treating glucose as an isolated number.

Glucose is a central fuel whose metabolism must be coordinated with energy demand and nutritional state. Glycolysis converts glucose to pyruvate while generating ATP and NADH. Under aerobic conditions, pyruvate can enter mitochondria and become acetyl-CoA; when oxidative handling is limited or absent, conversion to lactate regenerates NAD+ needed for continued glycolysis.

The pyruvate dehydrogenase reaction links glycolysis to the tricarboxylic acid cycle. The TCA cycle oxidizes acetyl units and produces reduced cofactors for oxidative phosphorylation. Glycogenesis stores glucose as glycogen, whereas glycogenolysis mobilizes glycogen. Gluconeogenesis produces glucose from suitable non-carbohydrate precursors during fasting.

The pentose-phosphate pathway generates NADPH and ribose-related intermediates. NADPH supports reductive biosynthesis and antioxidant defence; this is particularly important in cells exposed to oxidant stress.

Blood glucose is regulated by coordinated organ metabolism and hormones. Insulin favours postprandial utilization and storage, whereas glucagon and other counter-regulatory signals support glucose availability during fasting or stress. Liver, muscle and adipose tissue have different metabolic roles, so the same hormonal state produces tissue-specific consequences.

Mechanism map: fed state → insulin-dominant storage/utilization; fasting → hepatic glycogenolysis then greater gluconeogenic support; prolonged fasting → broader fuel adaptation. Track carbon flow and also track ATP, NADH and NADPH separately.

Clinical integration includes diabetes mellitus, hypoglycaemia, lactic acidosis, glycogen-storage disorders and red-cell vulnerability when NADPH generation is impaired.

Common confusion: glycolysis and gluconeogenesis are not simple reversible copies of each other; key irreversible steps require bypass reactions. Muscle glycogen mainly supports muscle itself, whereas hepatic metabolism has a major role in maintaining circulating glucose.